Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects
Low Dose Ketamine Infusion for Analgesia in the Emergency Department (ED) to Reduce Side Effects: A Double Blind, Double Dummy Randomized Controlled Trial
Sponsor: Summa Health System
Listed as NCT05518877, this PHASE4 trial focuses on Dissociation and Pain, Acute and remains completed. Sponsored by Summa Health System, it has been updated 12 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jun 2025 — Present [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2025 — Jun 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE4
▶ Show 7 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Apr 2024 [monthly]
Recruiting PHASE4
-
Sep 2023 — Oct 2023 [monthly]
Recruiting PHASE4
-
Aug 2023 — Sep 2023 [monthly]
Recruiting PHASE4
-
Feb 2023 — Aug 2023 [monthly]
Recruiting PHASE4
-
Jan 2023 — Feb 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Summa Health System
For direct contact, visit the study record on ClinicalTrials.gov .